Sombody was asking where the shares that are being sold come from. I was only pointing to this;
from the last 10-Q" In July 2012, we issued 2,000,000 shares of our common stock to holders of Series C Convertible Preferred Stock upon their exercise of the
conversion feature contained in those securities.
In August 2012, we issued 1,000,000 shares of our common stock in consideration for services rendered to the Company.
In September 2012, we issued 1,750,000 shares of our common stock in consideration for services rendered to the Company. "
In September 2012, we issued 3,000,000 shares of our common stock to holders of Series C C"
It could be that these folks sold there shares no big deal.
I posted this B4 and I paraphrase Dr Chains making a request to investors to be investors, not flippers for sordid gain, which I agree.
We continue to suffer from an enormously undervalued stock which I believe is the result of a few shareholders who for some reason are not invested in the long-term growth of the company. This single factor - their lack of support - is the largest hindrance to raising the new capital needed to advance our drug programs to points of value accretion where they can be partnered. My biggest hope for 2013 is for all of our stakeholders to recognize the tremendous inherent value of Intellect's remarkable discovery engine, intellectual property portfolio and pipeline and license
AI
